Proteome Sciences (LON:PRM) Trading Up 20.9% – Here’s Why

Proteome Sciences plc (LON:PRM)’s share price was up 20.9% on Friday . The company traded as high as GBX 2.40 ($0.03) and last traded at GBX 2.40 ($0.03). Approximately 223,086 shares traded hands during mid-day trading, a decline of 9% from the average daily volume of 245,400 shares. The stock had previously closed at GBX 1.99 ($0.03).

Proteome Sciences Price Performance

The company has a market capitalization of £7.08 million, a PE ratio of -2.12 and a beta of 0.07. The company has a current ratio of 0.20, a quick ratio of 0.37 and a debt-to-equity ratio of -258.66. The stock has a fifty day simple moving average of GBX 2.66 and a 200-day simple moving average of GBX 2.94.

Proteome Sciences (LON:PRM) last issued its earnings results on Thursday, September 25th. The company reported GBX (0.73) earnings per share for the quarter. Proteome Sciences had a negative return on equity of 0.01% and a negative net margin of 0.04%.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.